Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary

被引:16
作者
Hanna, Nasser H. [1 ]
Temin, Sarah [2 ]
Masters, Gregory [3 ]
机构
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA
[3] Helen F Graham Canc Ctr & Res Inst, Newark, DE USA
关键词
AMERICAN SOCIETY;
D O I
10.1200/JOP.19.00770
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E844 / E848
页数:5
相关论文
共 11 条
[1]   Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].
Brahmer, Julie R. ;
Lacchetti, Christina ;
Schneider, Bryan J. ;
Atkins, Michael B. ;
Brassil, Kelly J. ;
Caterino, Jeffrey M. ;
Chau, Ian ;
Ernstoff, Marc S. ;
Gardner, Jennifer M. ;
Ginex, Pamela ;
Hallmeyer, Sigrun ;
Chakrabarty, Jennifer Holter ;
Leighl, Natasha B. ;
Mammen, Jennifer S. ;
McDermott, David F. ;
Naing, Aung ;
Nastoupil, Loretta J. ;
Phillips, Tanyanika ;
Porter, Laura D. ;
Puzanov, Igor ;
Reichner, Cristina A. ;
Santomasso, Bianca D. ;
Seigel, Carole ;
Spira, Alexander ;
Suarez-Almazor, Maria E. ;
Wang, Yinghong ;
Weber, Jeffrey S. ;
Wolchok, Jedd D. ;
Thompson, John A. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+
[2]   Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].
Gandhi, L. ;
Rodriguez-Abreu, D. ;
Gadgeel, S. ;
Esteban, E. ;
Felip, E. ;
De Angelis, F. ;
Domine, M. ;
Clingan, P. ;
Hochmair, M. J. ;
Powell, S. F. ;
Cheng, S. Y. -S. ;
Bischoff, H. G. ;
Peled, N. ;
Grossi, F. ;
Jennens, R. R. ;
Reck, M. ;
Hui, R. ;
Garon, E. B. ;
Boyer, M. ;
Rubio-Viqueira, B. ;
Novello, S. ;
Kurata, T. ;
Gray, J. E. ;
Vida, J. ;
Wei, Z. ;
Yang, J. ;
Raftopoulos, H. ;
Pietanza, M. C. ;
Garassino, M. C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092
[3]   Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline [J].
Gilligan, Timothy ;
Coyle, Nessa ;
Frankel, RichardM. ;
Berry, Donna L. ;
Bohlke, Kari ;
Epstein, Ronald M. ;
Finlay, Esme ;
Jackson, Vicki A. ;
Lathan, Christopher S. ;
Loprinzi, Charles L. ;
Nguyen, Lynne H. ;
Seigel, Carole ;
Baile, Walter F. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) :3618-+
[4]   Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update [J].
Hanna, Nasser H. ;
Schneider, Bryan J. ;
Temin, Sarah ;
Baker, Sherman, Jr. ;
Brahmer, Julie ;
Ellis, Peter M. ;
Gaspar, Laurie E. ;
Haddad, Rami Y. ;
Hesketh, Paul J. ;
Jain, Dharamvir ;
Jaiyesimi, Ishmael ;
Johnson, David H. ;
Leighl, Natasha B. ;
Phillips, Tanyanika ;
Riely, Gregory J. ;
Robinson, Andrew G. ;
Rosell, Rafael ;
Schiller, Joan H. ;
Singh, Navneet ;
Spigel, David R. ;
Stabler, Janis O. ;
Tashbar, Joan ;
Masters, Gregory .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (14) :1608-+
[5]   Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden [J].
Hellmann, M. D. ;
Ciuleanu, T. -E. ;
Pluzanski, A. ;
Lee, J. S. ;
Otterson, G. A. ;
Audigier-Valette, C. ;
Minenza, E. ;
Linardou, H. ;
Burgers, S. ;
Salman, P. ;
Borghaei, H. ;
Ramalingam, S. S. ;
Brahmer, J. ;
Reck, M. ;
O'Byrne, K. J. ;
Geese, W. J. ;
Green, G. ;
Chang, H. ;
Szustakowski, J. ;
Bhagavatheeswaran, P. ;
Healey, D. ;
Fu, Y. ;
Nathan, F. ;
Paz-Ares, L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2093-2104
[6]   Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update [J].
Kalemkerian, Gregory P. ;
Narula, Navneet ;
Kennedy, Erin B. ;
Biermann, William A. ;
Donington, Jessica ;
Leighl, Natasha B. ;
Lew, Madelyn ;
Pantelas, James ;
Ramalingam, Suresh S. ;
Reck, Martin ;
Saqi, Anjali ;
Simoff, Michael ;
Singh, Navneet ;
Sundaram, Baskaran .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) :911-+
[7]   Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial [J].
Mok, Tony S. K. ;
Wu, Yi-Long ;
Kudaba, Iveta ;
Kowalski, Dariusz M. ;
Cho, Byoung Chul ;
Turna, Hande Z. ;
Castro, Gilberto, Jr. ;
Srimuninnimit, Vichien ;
Laktionov, Konstantin K. ;
Bondarenko, Igor ;
Kubota, Kaoru ;
Lubiniecki, Gregory M. ;
Zhang, Jin ;
Kush, Debra ;
Lopes, Gilberto .
LANCET, 2019, 393 (10183) :1819-1830
[8]  
Osman Hibah, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.18.00026
[9]   Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer [J].
Paz-Ares, L. ;
Luft, A. ;
Vicente, D. ;
Tafreshi, A. ;
Gumus, M. ;
Mazieres, J. ;
Hermes, B. ;
Senler, F. Cay ;
Csoszi, T. ;
Fulop, A. ;
Rodriguez-Cid, J. ;
Wilson, J. ;
Sugawara, S. ;
Kato, T. ;
Lee, K. H. ;
Cheng, Y. ;
Novello, S. ;
Halmos, B. ;
Li, X. ;
Lubiniecki, G. M. ;
Piperdi, B. ;
Kowalski, D. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) :2040-2051
[10]   Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC [J].
Socinski, M. A. ;
Jotte, R. M. ;
Cappuzzo, F. ;
Orlandi, F. ;
Stroyakovskiy, D. ;
Nogami, N. ;
Rodriguez-Abreu, D. ;
Moro-Sibilot, D. ;
Thomas, C. A. ;
Barlesi, F. ;
Finley, G. ;
Kelsch, C. ;
Lee, A. ;
Coleman, S. ;
Deng, Y. ;
Shen, Y. ;
Kowanetz, M. ;
Lopez-Chavez, A. ;
Sandler, A. ;
Reck, M. ;
Ahualli, A. ;
Jarchum, G. ;
Kaen, D. L. ;
Kahl, S. ;
Kotliar, M. ;
Kowalyszyn, R. D. ;
Lerzo, G. ;
Magri, I ;
Martin, C. ;
Pastor, A. ;
Picon, P. ;
Streich, G. ;
Varela, M. ;
Blinman, P. ;
Boyer, M. ;
Crombie, C. ;
Gauden, S. ;
Gill, S. ;
Hughes, B. ;
John, T. ;
Joshi, A. ;
Kosmider, S. ;
Lewis, C. ;
Millward, M. ;
Nordman, I ;
Nott, L. ;
O'Byrne, K. ;
Parnis, F. ;
Potasz, N. ;
Richardson, G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (24) :2288-2301